Optibiotix Health Share Discussion Threads

[croasdalelfc] 30/8/2017 09:32

The Group's cash position remains strong at GBP1,923,018 which is sufficient to cover the delivery of existing development and commercial plans.....This reads as no need for a cash raise

[michaelmouse] 30/8/2017 09:12

All the bulls on the other thread now pretending that GoFigure doesn't matter, and using my arguments about crowded markets and multi-million pound marketing spend needed.

LOL. You couldn't make it up.

GoFigure does matter otherwise why did they bother? Proof of concept is b*llsh*t and even if they are trying proof of concept then it's even more worrying since nobody is buying it.

Aimho of course.

[john henry] 30/8/2017 09:10

Not sure on the trades but would appear MMs are bidding well above MID.

[michaelmouse] 30/8/2017 09:00

Poor troll trying to make up usernames that are like mine. LOL. Imitation is the sincerest form of flattery.

According to their figures, revenues in the second half of last year were approx. £200,000. They have now dropped to around £75,000 despite launching Go-Figure and other sales? Something is amiss. It just doesn't add up does it?

As already stated Go-figure is not making any market penetration and sales have already slumped in a very short time.

Here's the problem, all their markets are already saturated with products and potions promising all sorts of wonderful life enhancing solutions. The marketing spend to crack those markets would need to be massive.

Revenues for the full year will be pitiful. They will need more cash.

Avoid imo.

Aimho of course.

[trotterstrading] 30/8/2017 08:59

Always the same reaction to results on the AIM. Steady as she goes, everything in line with expectation as far as I'm concerned. Go/figure has plateaued which is to be expected, weight Mgmt shakes/bars are highly competitive markets which need marketing ££'s and scale up to increase or even sustain market share. SoH and the team are fully aware of this and talks are in progress with major retailers in parallel with manufacturing scale up. Tata will bring a huge boost for slimbiome in the near future too

[riskybusiness1] 30/8/2017 08:49

Looks like the listing of skinbio has increased the admin costs by about 300,000. I think this was roughly the amount opti lent skinbio as convertible loan. This would have converted to shares in skinbio in march when it listed hence at first glance larger cash burn. Tidy profit on investment though made clear. Scotty etc....the only revenues will be from go figure, run by someone called max tomlinson and not advertised. Products only officially launched in may....results ending may.....18 months of cash left if opti didn't sell a penny from now costs may also be slightly less now due to delisting skin.

[john henry] 30/8/2017 08:47

Back testing the break above 67p. Volume is minimal a few decent buys and the share price should recover 70p

[tsmith2] 30/8/2017 08:42

Jam jam jam

[vanduke] 30/8/2017 08:39

Why are revenue figures not give when deals are signed??The RNS can be vague??

[pugg1ey] 30/8/2017 08:36

they got their first German sales in April of '100000 units' so that will be in the figures, Clearly 100000 units isn't very much at all in terms of revenue hence the actual cost in £'s wasn't given. Need to be more transparent with the cash value of deals imo.

[primal123] 30/8/2017 08:34

Really don't know what people expected today. Obviously expecting huge sales which is ridiculous when it's the results ending may 17! Let's see what happens from now on!

[vanduke] 30/8/2017 08:32

Just keep buying...

[jestercat2] 30/8/2017 08:27

I expect a fairly muted market reaction (either way). The figures are in line with expectations and all the news was already out there - useful summary and good to see it all in one place but doesn't really tell us any more than we already knew.

However it does underline how bright the future is looking and I reckon the period from now until the end of the year will be highly interesting.

[primal123] 30/8/2017 08:25

Judi - we bothered as this reeled in TATA.

[michael1mouse] 30/8/2017 08:25

Bars and shakes = tata

[vanduke] 30/8/2017 08:23

Keep buying..

[judijudi] 30/8/2017 08:21

I have always thought that the bars and powders are just a sideline
Not sure why we bothered really
Much much bigger fish to fry
bwtfdik

[michael1mouse] 30/8/2017 08:18

Come now michael, how are the results worse than even you imagined? You have been arguing for a fund raise for a year. This has been dispelled by your good friend Tom Winnifroth. Surely you must ignore the one off costs in the accounts for the sbtx ipo, After accounting for the adjustment, the Operating Loss for the period is GBP0.98m (2016: GBP0.71m). The increase in loss reflects the inclusion of the first set of six monthly results for The Healthy Weight Loss Company (GBP40K) and Skinbiotherapeutics plc (GBP233K). Following the listing of SkinBiotherapeutics plc whilst we have to account for our share (41.9%) of future profits or losses, as this is an accounting adjustment, there is no impact on OptiBiotix group cash balance. Cashflow remains tightly controlled with a focus on building shareholder value through investment in R&D, IP and in-licensing opportunities. The Group's cash position remains strong at GBP1,923,018 which is sufficient to cover the delivery of existing development and commercial plans. It is obvious no funding issues are evident and the business model is structure such a way that partners pay for the rollout of the products, so no additional funds required for the big commercial push, typically needed when a company transitions from r&d to commercial. Do any companies you are invested in have the same astute business models? If they do, please tell me cos i would very much like to run the rule over them for an investment case of my own.

all in my opinion of course.

[winner31] 30/8/2017 08:16

Sales are poor. Its going to take time

[john henry] 30/8/2017 08:13

Go figure from online sales etc to the end of May are not going to amount to much.

[rafboy] 30/8/2017 08:13

The results reflect where we are as a company. There will always be a greater spend prior to launching products and dispersing assets. This expenditure reflects how the company is transitioning from production to commercialisation. What we should see now over the coming months and years is an increasing revenue as our products are taken up and sold across the globe. It is only if this fails to happen that I would become concerned but I have every confidence in the OPTI team to deliver.

As many have commented, including myself, the SBTX disposal was not handled well. The company are aware I'm sure of our feelings. However, it is clear they wish to see the market cap increase before taking further action.

[john henry] 30/8/2017 08:10

Sales what from Scotty

[scotty1] 30/8/2017 08:02

I do understand that Primal.But i really did expect to see a little more on sales etc,will have to wait and see how market reacts today.

[primal123] 30/8/2017 07:59

Scotty - need to have a bit of patience as the commercial side has only just started! They aren't going to get huge income already when LP-LDL has just been commercialised! These are huge markets and in time should bring in big profits.